# Par Formulations Private Limited – FDA Inspection, Jun 21, 2019

Source: https://www.keypedia.com/records/fda_inspections/par-formulations-private-limited/319654a7-64af-45fd-8db5-1d83c3aca752
Source feed: FDA_Inspections

> FDA inspection 1098295 of Par Formulations Private Limited, June 21, 2019. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1098295
- Company Name: Par Formulations Private Limited
- Inspection Date: 2019-06-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1321302 - 2026-06-10](https://www.keypedia.com/records/fda_inspections/par-formulations-private-limited/a38f8c1a-1d1c-4370-b5f3-109e9180eab1)
- [FDA Inspection 1205764 - 2023-03-24](https://www.keypedia.com/records/fda_inspections/par-formulations-private-limited/d4aa028e-e5ab-42d0-a606-4f7087a25014)
- [FDA Inspection 1000693 - 2016-12-07](https://www.keypedia.com/records/fda_inspections/par-formulations-private-limited/68eee17f-7ca7-4bfc-9750-e99cebca3f65)
- FDA Inspection 927362 - 2015-04-17
- FDA Inspection 855562 - 2013-10-17

## Related Officers

- [Investigator](https://www.keypedia.com/people/jose-a-lopez-rubet/1d1f18e7-bb35-442f-829e-e21b0c081bfa)
- [FDA Associated Person](https://www.keypedia.com/people/nicole-e-knowlton/8e65400f-249f-45fe-96fc-cb00fec6ae39)

Company: https://www.keypedia.com/companies/par-formulations-private-limited/f804e8f7-719b-45b4-9aae-3aea30adf070

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
